{
    "2021-03-25": [
        [
            {
                "time": "",
                "original_text": "阿斯利康新冠疫苗风波又起，拿下中国代理权的康泰生物还好吗？",
                "features": {
                    "keywords": [
                        "阿斯利康",
                        "新冠疫苗",
                        "风波",
                        "康泰生物"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物、康泰生物极速跳水，疫苗板块回落",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "康泰生物",
                        "跳水",
                        "疫苗板块",
                        "回落"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-01",
                "original_text": "2021年1-2月疫苗批签发数据跟踪报告：二类疫苗快速增长，热门大品种表现亮眼",
                "features": {
                    "keywords": [
                        "疫苗",
                        "批签发",
                        "二类疫苗",
                        "快速增长",
                        "热门大品种"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}